Development and clinical research of a multifunctional central cardiovascular pathway electrocardiographic guidance positioning device

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048374

Enrollment

Unknown

Registered

2021-07-06

Start date

2022-07-01

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Intervention group:Multifunctional central cardiovascular pathway electrocardiographic guidance positioning device intubation

Control group:X - ray chest radiograph location

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients who are planning to be placed in the middle cardiovascular pathway due to treatment, aged >=18 years; 2.The basic ECG record before the catheterization showed normal P wave; 3.Agree to participate in this study, and sign the informed consent form for CVADs placement and this study.

Exclusion criteria

Exclusion criteria: 1.Patients with various heart diseases, such as valvular heart disease, atrial fibrillation, supraventricular tachycardia, pulmonary heart disease, or patients with pacemaker implantation and cardiac surgery that may cause P wave changes; 2.Patients who cannot lie supine or semi-lying.

Design outcomes

Primary

Measure	Time frame
One-time positioning accuracy;Distance of catheter tip from right atrial junction;	—

Countries

China

Contacts

Public ContactYuan Ling

Drum Tower Hospital Affiliated to Nanjing University School of Medicine

yuanling73@hotmail.com+86 13851517407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026